Breaking News Instant updates and real-time market news.

BAYRY

Bayer

$106.77

-0.905 (-0.84%)

, MON

Monsanto

$108.48

0.04 (0.04%)

15:24
01/11/17
01/11
15:24
01/11/17
15:24

Bayer, Monsanto execs pitch tie-up to Trump, WSJ says

Top executives at Bayer (BAYRY) and Monsanto (MON) held a meeting with Donald Trump in New York to pitch their proposed tie-up to the U.S. president-elect, the Wall Street Journal reports. Bayer CEO Werner Baumann and Monsanto CEO Hugh Grant outlined the planned $57B transaction, the report says, citing representatives for the companies. Several members of Trump's agricultural advisory committee have spoken out against such large deals and called for Trump to block them, the report notes. Reference Link

BAYRY

Bayer

$106.77

-0.905 (-0.84%)

MON

Monsanto

$108.48

0.04 (0.04%)

  • 19

    Jan

  • 27

    Jan

BAYRY Bayer
$106.77

-0.905 (-0.84%)

12/19/16
JEFF
12/19/16
DOWNGRADE
Target $48
JEFF
Underperform
Merck downgraded to Underperform from Hold at Jefferies
Jefferies analyst Jeffrey Holford downgraded Merck (MRK) to Underperform, his firm's sell-rating equivalent. The analyst sees Pharmaceutical sector fundamentals weakening in 2017 amid political overhangs and an adverse macro environment. Potential dual eligible rebate reform is the most significant risk, Holford tells investors in a research note. Specific to Merck, the analyst expects further pressure on Keytruda in 2018, driven by share losses in non-small cell lung cancer to Bristol-Myers Squibb (BMY), AstraZeneca (AZN) and Roche (RHHBY). Merck screens poorly on many valuation metrics, Holford contends. He lowered his price target for the shares to $48 from $59. The stock closed Friday up 7c to $62.44. The analyst this morning also upgraded both Bristol-Myers Squibb (BMY) and Bayer (BAYRY) to Buy from Hold. His top picks in Pharmaceuticals are AbbVie (ABBV) and Eli Lilly (LLY) for the U.S. and AstraZeneca and Novartis (NVS) in Europe.
12/19/16
12/19/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) and Bayer (BAYRY) were upgraded to Buy from Hold at Jefferies. 2. Costco (COST) upgraded to Buy from Neutral at Citi with analyst Kate McShane saying she sees a "clear path" to accelerating same-store-sales growth in fiscal 2017 as gasoline price deflation headwinds abate and benefits arise from the new co-branded credit card. 3. United Technologies (UTX) upgraded to Outperform from Neutral at Credit Suisse with analyst Julian Mitchell saying he believes consensus estimates are poised to move higher after years of heavy investment spending drive an earnings recovery. 4. ASML (ASML) upgraded to Buy from Neutral at BofA/Merrill with analyst Kai Korschelt saying a recent expert's call indicates progress with Extreme Ultraviolet/EUV lightsource optics & ecosystem and sees improving volume visibility from 2018 forward. 5. Gulfport Energy (GPOR) upgraded to Buy from Neutral at Guggenheim and to Overweight from Equal Weight at Stephens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/04/17
JPMS
01/04/17
UPGRADE
JPMS
Overweight
Bayer upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Richard Vosser upgraded Bayer to Overweight saying the valuation is "cheap" while the company has limited exposure to Pharma sector headwinds.
01/06/17
JPMS
01/06/17
NO CHANGE
Target $128
JPMS
Overweight
Monsanto shares are mispriced, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas says Monsanto (MON) shares are mispriced and offer an attractive risk/reward proposition. A first catalyst for the shares would be regulatory agreement in the Dow Chemical (DOW)/DuPont (DD) transaction, Zekauskas tells investors in a research note. The analyst thinks a favorable resolution to the Dow/DuPont merger would be seen as improving the probability of the success of the Bayer/Monsanto transaction. He notes that Bayer has agreed to purchase Monsanto for $128 per share in cash, which represents 21% appreciation potential should the deal close by year-end. Zekauskas thinks a "reasonable floor" price for Monsanto shares, should the deal fail, is $102. He keeps an Overweight rating on the name with a $128 price target.
MON Monsanto
$108.48

0.04 (0.04%)

11/18/16
OTRG
11/18/16
UPGRADE
OTRG
Mixed
Monsanto upgraded to Mixed from Negative at OTR Global
01/06/17
LYON
01/06/17
UPGRADE
LYON
Outperform
Monsanto upgraded to Outperform from Underperform at CLSA
01/06/17
LYON
01/06/17
UPGRADE
LYON
Outperform
Monsanto upgraded to Outperform on valuation at CLSA
As previously reported, CLSA upgraded Monsanto to Outperform from Underperform and raised its price target to $115 from $110. Analyst Mark Connelly continues to see a very high chance that the deal with Bayer will be rejected, he no longer see significant risk to the stock below $90, making the risk reward more attractive.

TODAY'S FREE FLY STORIES

SPB

Spectrum Brands

$121.30

-3.86 (-3.08%)

16:32
01/18/18
01/18
16:32
01/18/18
16:32
Hot Stocks
Spectrum Brands postpones 2018 annual shareholder meeting »

Spectrum Brands Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 30

    Jan

  • 08

    Feb

NTIP

Network-1 Technologies

$2.50

0.05 (2.04%)

, JNPR

Juniper

$27.66

-1.01 (-3.52%)

16:32
01/18/18
01/18
16:32
01/18/18
16:32
Hot Stocks
Network-1 Technologies announces revised patent settlement with Juniper »

Network-1 Technologies…

NTIP

Network-1 Technologies

$2.50

0.05 (2.04%)

JNPR

Juniper

$27.66

-1.01 (-3.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

ENFC

Entegra Financial

$28.90

-0.7 (-2.36%)

16:31
01/18/18
01/18
16:31
01/18/18
16:31
Earnings
Entegra Financial reports Q4 core EPS 54c, consensus 38c »

Reports Q4 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

WYNN

Wynn Resorts

$175.48

1.89 (1.09%)

16:30
01/18/18
01/18
16:30
01/18/18
16:30
Initiation
Wynn Resorts initiated  »

Wynn Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
01/18/18
01/18
16:30
01/18/18
16:30
Options
Preliminary option volume of 20.9M today »

Preliminary option volume…

NTES

NetEase

$322.19

-2.21 (-0.68%)

16:29
01/18/18
01/18
16:29
01/18/18
16:29
Recommendations
NetEase analyst commentary  »

NetEase price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

MS

Morgan Stanley

$55.84

0.49 (0.89%)

, AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

16:25
01/18/18
01/18
16:25
01/18/18
16:25
General news
On The Fly: Top stock stories for Thursday »

Stocks opened little…

MS

Morgan Stanley

$55.84

0.49 (0.89%)

AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

LGF.A

Lionsgate

$34.50

2.22 (6.88%)

LGF.B

Lionsgate

$32.84

2.46 (8.10%)

CBS

CBS

$60.00

1.1 (1.87%)

VIA

Viacom

$39.70

1.85 (4.89%)

VIAB

Viacom

$33.95

1.99 (6.23%)

BA

Boeing

$340.16

-10.85 (-3.09%)

ERJ

Embraer

$24.50

-0.19 (-0.77%)

GNC

GNC Holdings

$5.26

1.79 (51.59%)

PTC

PTC

$69.95

3.25 (4.87%)

AA

Alcoa

$53.00

-3.99 (-7.00%)

ENDP

Endo

$7.35

-0.34 (-4.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

  • 31

    Jan

  • 01

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

  • 21

    Feb

  • 18

    Mar

SRG

Seritage Growth Properties

$40.37

-0.4 (-0.98%)

16:25
01/18/18
01/18
16:25
01/18/18
16:25
Hot Stocks
Seritage Growth Properties sees FY17 leasing activity 2.6M sqf, up 26% on year »

Seritage Growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNST

Monster Beverage

$66.47

-0.6 (-0.89%)

16:25
01/18/18
01/18
16:25
01/18/18
16:25
Conference/Events
Monster Beverage to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

MGM

MGM Resorts

$36.07

-0.47 (-1.29%)

, WYNN

Wynn Resorts

$175.48

1.89 (1.09%)

16:23
01/18/18
01/18
16:23
01/18/18
16:23
Initiation
MGM Resorts, Wynn Resorts, Eldorado Resorts, Penn National initiated  »

MGM Resorts initiated…

MGM

MGM Resorts

$36.07

-0.47 (-1.29%)

WYNN

Wynn Resorts

$175.48

1.89 (1.09%)

ERI

Eldorado Resorts

$31.60

-0.4 (-1.25%)

PENN

Penn National

$32.26

-0.49 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BANF

BancFirst

$55.20

0.95 (1.75%)

16:22
01/18/18
01/18
16:22
01/18/18
16:22
Hot Stocks
BancFirst to raise company minimum wage »

Executive Chairman David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$23.82

-0.3 (-1.24%)

16:22
01/18/18
01/18
16:22
01/18/18
16:22
Hot Stocks
Meritor realigns segments and leadership positions »

Meritor is realigning its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 13

    Feb

  • 14

    Feb

BANF

BancFirst

$55.20

0.95 (1.75%)

16:21
01/18/18
01/18
16:21
01/18/18
16:21
Earnings
BancFirst reports Q4 EPS 59c, consensus 69c »

Due to the signing of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHN

athenahealth

$125.53

-0.65 (-0.52%)

16:20
01/18/18
01/18
16:20
01/18/18
16:20
Initiation
athenahealth initiated  »

athenahealth initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

VIX

Volatility Index S&P 500 Options

16:20
01/18/18
01/18
16:20
01/18/18
16:20
Options
Closing CBOE SPX and VIX Index summary for January 18th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$99.86

-0.9 (-0.89%)

16:19
01/18/18
01/18
16:19
01/18/18
16:19
Hot Stocks
Breaking Hot Stocks news story on American Express »

American Express down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

MRCY

Mercury Systems

$51.26

-0.45 (-0.87%)

16:19
01/18/18
01/18
16:19
01/18/18
16:19
Hot Stocks
Mercury Systems receives $12.5M electronic surveillance subsystem order »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

HCLP

Hi-Crush Partners

$12.00

-0.05 (-0.41%)

16:18
01/18/18
01/18
16:18
01/18/18
16:18
Hot Stocks
Hi-Crush Partners increases distribution to 20c per unit for Q4 »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFBC

First Financial Bancorp

$27.75

-0.4 (-1.42%)

16:17
01/18/18
01/18
16:17
01/18/18
16:17
Earnings
First Financial Bancorp reports Q4 adjusted EPS 45c, consensus 40c »

Claude Davis, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

$NSD

NASDAQ Market Internals

16:17
01/18/18
01/18
16:17
01/18/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCRI

Monarch Casino

$45.40

-0.5 (-1.09%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Initiation
Monarch Casino initiated  »

Monarch Casino initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVS

Las Vegas Sands

$73.73

0.22 (0.30%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Initiation
Las Vegas Sands initiated  »

Las Vegas Sands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

EPR

EPR Properties

$59.55

-1.24 (-2.04%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Hot Stocks
EPR Properties raises monthly dividend to 36c from 34c »

The dividend of $0.36 per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPP

Green Plains Partners

$18.00

0.1 (0.56%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Hot Stocks
Green Plains Partners increases quarterly distribution »

Green Plains Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFBC

First Financial Bancorp

$27.75

-0.4 (-1.42%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Earnings
First Financial Bancorp reports Q4 EPS 40c, consensus 40c »

Net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.